The largest database of trusted experimental protocols

Macs tumor dissociation kit

Manufactured by Miltenyi Biotec
Sourced in Germany

The MACS Tumor Dissociation Kit is a laboratory tool designed to facilitate the mechanical and enzymatic dissociation of solid tumor tissue samples into single-cell suspensions. The kit contains optimized reagents and protocols to isolate viable cells from a variety of tumor types.

Automatically generated - may contain errors

25 protocols using macs tumor dissociation kit

1

Establishment of Patient-Derived Organoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Surgical specimens were obtained by the core needle biopsy of surgically removed tumors. The specimens were dissociated into single cells using a MACS Tumor Dissociation Kit and a gentle MACS dissociator (Miltenyi Biotec, North Rhine-Westphalia, Germany) in accordance with the manufacturer’s instruction. For pleural effusion specimens, drainage fluid was collected after trocar placement, centrifuged, and purified with Red Blood Cell Lysis Solution lysis buffer (Miltenyl Biotec). The organoids were established from the obtained cells as described previously [8 (link)]. Briefly, cell pellets were resuspended in BME gel (R&D Systems, Minnesota, USA) at 4 °C and seeded to form domes in 24-well or 48-well plates (IWAKI, Tokyo, Japan), polymerized at 37 °C for 10–20 min, and the prepared medium was added at a volume of 500 mL per 50 µL BME dome. The medium was changed every 3–4 days and the PDO was passaged depending on growth. Cultrex Organoid Harvesting Solution (Thermo Fisher Scientific, Massachusetts, USA) and 0.25 w/v% Trypsin-1 mM EDTA 4Na Solution with Phenol Red (FUJIFILM, Tokyo, Japan) were used for passaging of organoids. Expression of ER and PgR in surgical specimens was assessed using the Allred score [12 (link)].
+ Open protocol
+ Expand
2

Isolating PBMCs and Tumor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
De-identified peripheral blood samples from healthy human subjects (see Supplementary Table 2) were obtained and experimental procedures were carried out in accordance with the guidelines of the Stanford Institutional Review Board (IRB). Written informed consent was obtained from all subjects. Fresh whole human blood in heparin collection tubes or leukoreduction system chamber contents (Terumo BCT) were obtained via the Stanford Blood Center. PBMCs were isolated via Ficoll (GE Healthcare) density gradient centrifugation.
FFPE tissue samples were obtained from the tissue repository of the Stanford Department of Pathology. Colorectal carcinoma and healthy adjacent tissue samples for mass cytometry (see Supplementary Table 2) were collected fresh after resection and transported for processing on ice in cell culture medium (CCM: RPMI-1640 (life technologies), 10% FBS, 1x L-glutamine, 1x penicillin/streptomycin (Thermo Fisher)). Samples were minced and processed using the MACS tumor dissociation kit (Miltenyi Biotec) as recommended. All viable single-cell suspensions were frozen in FBS supplemented with 10% DMSO and stored in liquid nitrogen.
+ Open protocol
+ Expand
3

Apoptotic Cell Determination in Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
For apoptotic cell determination, the tumors were dissociated to single cells using the MACS Tumor Dissociation Kit in combination with the gentleMACS Dissociator (Miltenyi Biotec) as according to the manufacturer’s protocol. After dissociation, the cells were filtered through a 30 µm MACS SmartStrainer. Cells were pelleted from the filtrate at 300 g x 7 min and resuspended in 400 µl Binding Buffer. The cells were incubated with Annexin V FITC and Propidium Iodide (Sigma Aldrich) for 15 min in the dark at room temperature. After incubation, the cells were pelleted and resuspended in 100 µl Binding Buffer for analysis by flow cytometry using BD Accuri C6 cytometer (BD Biosciences, CA, USA).
+ Open protocol
+ Expand
4

Bladder Tumour Tissue Processing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bladder specimens were obtained fresh from the operating field where grossly apparent tumour tissue or adjacent tissue not grossly affected by tumour (Par-cancer tissue). These tissues were transported at room temperature immersed in the RPMI-1640 medium (Gibco, Gaithersburg, MD, USA) with 10% FBS (MilliporeSigma, Burlington, MA, USA). Once received, tumour tissues were divided into two parts, one of which was cut into approximately 1 mm3 pieces and enzymatically digested to single cell suspensions using MACS tumor dissociation kit (Miltenyi Biotec) for 1 h on a rotor at 37 °C for further flow cytometry/FACS analysis, another part of tumour tissues and all par-cancer tissues were frozen in liquid nitrogen immediately and then stored at − 80 °C until lncRNA extraction.
+ Open protocol
+ Expand
5

Isolation of CD45+ and CD3+ Immune Cells from MC38 Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
MC38 tumors, spleen and tumor draining lymph nodes were harvested at day 10 or day 20 post inoculation. Tumor tissues were cut into approximately 1 mm3 pieces in the RPMI-1640 medium (Invitrogen) with 2% fetal bovine serum (FBS), and enzymatically digested with MACS tumor Dissociation Kit (Miltenyi Biotec) for 40 min on gentleMACS™ Dissociator according to manufacturer’s instruction. The dissociated cells were subsequently passed through a 70 μm cell strainer and centrifuged at 500 g for 10 min. After the supernatant was removed, cells were re-suspended in MACS buffer (1x PBS with 2mM EDTA and 0.5% BSA) and counted. CD45+ cells were isolated with CD45 (TIL) MicroBeads (Miltenyi Biotec). Enriched CD45+ cells were washed and re-suspended in FACS buffer (1x PBS with 2% FBS) and stained for CD3e. CD3+ live cells were sorted by BD FACSMelody™. Spleen and draining lymph node were gently mashed and washed through a 70 μm cell strainer with culture medium. After centrifugation at 500g for 5 minutes, red blood cells in the spleen were removed by ACK lysing buffer. Cell pellets were finally re-suspended in FACS buffer and stained for CD3e. CD3+ live cells were sorted by BD FACSMelody™
+ Open protocol
+ Expand
6

Breast Cancer Specimen Dissociation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Breast cancer specimens were obtained by core needle biopsy of surgically removed tumors. Specimens were dissociated into single cells using a MACS Tumor Dissociation Kit and a gentle MACS dissociator (Miltenyi Biotec) according to the manufacturer’s instructions. All participants gave written informed consent before the collection of specimens. The protocol was approved by the institutional ethical committee of Cancer Institute Hospital, Japanese Foundation for Cancer Research (No. 2018-1168).
+ Open protocol
+ Expand
7

Tumor Tissue Dissociation for Single-Cell RNA-Seq

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh samples isolated from patients in operation were preserved in MACS Tissue Storage Solution (Miltenyi Biotec) at 4 °C. Tumor tissues were cut into a range of 0.2–1.0 g small pieces and dissociated in 5 mL enzyme mix containing 4.7 ml RPMI 1640 (Gibco), 200 μL Enzyme H, 100 μL Enzyme R and 25 μL Enzyme A (Miltenyi Biotec, MACS Tumor Dissociation Kit, human). The samples were subsequently incubated in a 37 °C thermostatic shaker for 35 min. Then suspended samples were filtered through a 40-μm Cell-Strainer nylon mesh (BD) with 30 mL of RPMI 1640 and centrifuged at 300 × g for 7 min. After removing the supernatant, we used Red Blood Cell Lysis Solution (Miltenyi Biotec #130-094-183) and the Dead Cell Removal Kit (Miltenyi Biotec #130-090-101) to remove red blood cells and obtain live cells. Cell suspension was centrifugated at 300 × g for 7 min and the pellet was re-suspended in 1 mL PBS solution. Once the desired cell suspension was obtained, the sample was immediately placed on ice for subsequent GEMs preparation and reverse transcription. The single cell libraries were prepared according to the standard protocols and sequenced on Illumina NovaSeq 6000 Systems using paired-end sequencing (150 bp in length).
+ Open protocol
+ Expand
8

Tumor Microenvironment Modulation by Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 1 × 105 HaCaT or A-5RT3 cells were admixed with 2 × 105 CAFs and 1 × 105VybrantDiO (Life Technologies, Waltham, MA, USA)-labeled FIBs in growth factor-reduced Matrigel (Corning, Tewksbury, MA, USA), with or without 500 U/ml catalase (Sigma), and implanted subcutaneously into NSG mice (Jackson Laboratory, Bar Harbor, ME, USA) (Figure 3a). Three weeks post-implantation, tumors were excised and dissociated using the MACS tumor dissociation kit and a gentleMACS Octo Dissociator (Miltenyi Biotec, Germany). Then, the tumors were doubly stained with CellROX Deep Red (Thermo, Waltham, MA, USA) and PE-conjugated anti-FAP antibody (Novus Biologicals, Littleton, CO, USA) for FACS. A total of 3 × 105 ROShigh/FAPhightFIBs were isolated and adoptively transferred into new tumor xenografts containing either HaCaT or A-5RT3 cells. Tumor growth was monitored for 3 weeks. All animal studies were approved by the Institutional Animal Care and Use Committee of Nanyang Technological University (ARF-SBS/NIE-A0216AZ).
+ Open protocol
+ Expand
9

Tumor Dissociation and Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice with tumor size about 8 mm in diameter were euthanized by cervical dislocation under deep anesthesia (lack of response to a toe pinch). Target (tumor) and control (spleen, blood) tissues were collected and dissociated into single cells. Tumor cell suspensions were obtained using MACS tumor dissociation kit from Miltenyi Biotec, Inc. (Bergisch Gladbach, Germany). Spleen cells were dissociated by grinding the tissue on a 70 μm cell strainer using a syringe plunger. Cell suspensions from all tissues were treated with red blood cell lysis buffer before they were incubated with peptides or antibodies at 4 °C for 1 h (both primary and secondary antibodies). TruStain fcX™ (rat anti-mouse CD16/32) antibody was included in the primary antibody staining step as the Fc blocking agent. Cells were washed with PBS between steps and analyzed on BD LSRFortessa (BD Biosciences, San Jose, CA). The flow cytometry data were then analyzed using FlowJo.
+ Open protocol
+ Expand
10

Single-cell ATAC-seq from tumor biopsies

Check if the same lab product or an alternative is used in the 5 most similar protocols
BC specimens were obtained by core needle biopsy of surgically removed tumours. Specimens were dissociated into single cells using a MACS Tumor Dissociation Kit and a gentleMACS Dissociator (Miltenyi Biotec) according to the manufacturer’s instructions. Cells were cryopreserved in Bambanker freezing medium (Nippon Genetics) for ATAC-seq analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!